D.E. Shaw & Co’s Genomic Health, Inc. GHDX Stock Holding History

D.E. Shaw & Co’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-22,000	Closed	-$1.42M	–	4083
2018 Q4	$1.42M	Buy	22,000 +17,700	+412%	+$1.24M	﹤0.01%	2423
2018 Q3	$302K	Buy	+4,300	New	+$252K	﹤0.01%	3359
2014 Q3	–	Sell	-40,000	Closed	-$1.1M	–	4522
2014 Q2	$1.1M	Buy	40,000 +20,000	+100%	+$532K	﹤0.01%	2853
2014 Q1	$527K	Buy	+20,000	New	+$574K	﹤0.01%	3568

D.E. Shaw & Co's GHDX Position: Q4 2019 in Review

D.E. Shaw & Co sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 71,478 shares — an estimated $4.85M sold.

D.E. Shaw & Co first reported a position in GHDX in Q2 2013 and held it in 23 quarters. The position peaked at $16.7M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

D.E. Shaw & Co reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
D.E. Shaw & Co sold 71,478 Genomic Health, Inc. shares in Q4 2019, an estimated $4.85M.
D.E. Shaw & Co first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 23 quarters.
D.E. Shaw & Co's Genomic Health, Inc. position peaked at $16.7M in Q2 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.